sonar-pro
Permits stability data submission for pharmaceutical products at 25째C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "78dd7f58-909b-4f4a-871e-d08c30cdca7f",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\n  \"answer\": \"NO\",\n  \"note\": \"Thailand, as a member of ASEAN, follows the ASEAN Guideline on Stability Study of Drug Product, which requires stability data to be generated at climatic Zone IVb conditions, specifically 30째C/75% RH, for product registration[3]. Stability data generated at 25째C/60% RH, even when supported by accelerated stability studies, is not considered sufficient for long-term registration in Thailand. If data are submitted at less stressful conditions (such as 25째C/60% RH), the submission does not fulfill Thailand's regulatory requirements and may not be accepted[3][2].\"\n}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755743778,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 137,
    "prompt_tokens": 31,
    "total_tokens": 168,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://www.artixio.com/post/thailand-fda-regulations-for-pharmaceutical-registration",
    "https://www.pharmoutsourcing.com/Featured-Articles/37672-Regulatory-Strategy-for-Long-Term-Stability-Conditions-to-Support-Submission-in-Zone-IV-Countries/",
    "https://asean.org/wp-content/uploads/2018/01/25PPWG-ANNEX-7-iv-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2.pdf",
    "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
    "https://clinregs.niaid.nih.gov/country/thailand"
  ],
  "search_results": [
    {
      "title": "Thai FDA Pharma Regulations & Registration Process in Thailand",
      "url": "https://www.artixio.com/post/thailand-fda-regulations-for-pharmaceutical-registration",
      "date": "2025-08-04",
      "last_updated": "2025-06-22"
    },
    {
      "title": "Regulatory Strategy for Long-Term Stability Conditions to ...",
      "url": "https://www.pharmoutsourcing.com/Featured-Articles/37672-Regulatory-Strategy-for-Long-Term-Stability-Conditions-to-Support-Submission-in-Zone-IV-Countries/",
      "date": "2011-03-01",
      "last_updated": "2025-08-21"
    },
    {
      "title": "[PDF] asean guideline on stability study of drug product",
      "url": "https://asean.org/wp-content/uploads/2018/01/25PPWG-ANNEX-7-iv-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2.pdf",
      "date": "1997-07-02",
      "last_updated": "2025-08-10"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
      "date": null,
      "last_updated": "2025-03-27"
    },
    {
      "title": "Clinical Research Regulation For Thailand - ClinRegs",
      "url": "https://clinregs.niaid.nih.gov/country/thailand",
      "date": "2025-04-21",
      "last_updated": "2025-06-18"
    }
  ]
}